Literature DB >> 9798591

Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease.

C F Lippa, L E Nee, H Mori, P St George-Hyslop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9798591     DOI： 10.1016/s0140-6736(05)79757-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats.

Authors:  Gao-Shang Chai; Dong-Xiao Duan; Rong-Hong Ma; Jian-Ying Shen; Hong-Lian Li; Zhi-Wei Ma; Yu Luo; Lu Wang; Xin-Hua Qi; Qun Wang; Jian-Zhi Wang; Zelan Wei; Darrell D Mousseau; Li Wang; Gongping Liu
Journal:  Neurosci Bull       Date:  2014-11-12       Impact factor: 5.203

2.  Vaccine trial in Alzheimer's disease is halted.

Authors:  Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

3.  Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats.

Authors:  Yu-Fang Cheng; Chuang Wang; Huan-Bing Lin; Yun-Feng Li; Ying Huang; Jiang-Ping Xu; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2010-07-17       Impact factor: 4.530

Review 4.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

5.  Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease.

Authors:  Yuesong Gong; Carol F Lippa; Jinghua Zhu; Qishan Lin; Andrea L Rosso
Journal:  Brain Res       Date:  2009-07-25       Impact factor: 3.252

6.  Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome.

Authors:  Carol F Lippa; Andrea L Rosso; Lauren D Stutzbach; Manuela Neumann; Virginia M-Y Lee; John Q Trojanowski
Journal:  Arch Neurol       Date:  2009-12

7.  Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease.

Authors:  Mei-Ping Kung; Catherine Hou; Zhi-Ping Zhuang; Daniel M Skovronsky; Bin Zhang; Tamar L Gur; John Q Trojanowski; Virginia M Y Lee; Hank F Kung
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

8.  Axon degeneration is key component of neuronal death in amyloid-β toxicity.

Authors:  Wilson M Alobuia; Wei Xia; Bhupinder P S Vohra
Journal:  Neurochem Int       Date:  2013-09-29       Impact factor: 3.921

Review 9.  Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways.

Authors:  C Bohm; F Chen; J Sevalle; S Qamar; R Dodd; Y Li; G Schmitt-Ulms; P E Fraser; P H St George-Hyslop
Journal:  Mol Cell Neurosci       Date:  2015-03-04       Impact factor: 4.314

10.  The rat as an animal model of Alzheimer's disease.

Authors:  Eirikur Benedikz; Ewa Kloskowska; Bengt Winblad
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.